Design
Review
Authors
Loading...
Sotalol may be considered for arrhythmia suppression with QT monitoring; leaves open its comparative safety and efficacy versus alternatives pending RCTs.
Sotalol is a unique antiarrhythmic agent with both beta-blocking and Class III properties, effective for various arrhythmias but requiring caution regarding QT prolongation and torsade de pointes.
Rodolphe Ruffy (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: